Mr. Chair, I would say it's more a question of the tool that's required to get the job done rather than a question of time frames or whether approaching our department through the strategic innovation fund is the longer-term negotiation or more complicated. I think the strategic innovation fund in the days ahead is the key tool to unlock the R and D potential, particularly to support vaccine and therapeutic development in the country.
It's not a matter at this point where you're doing a contract; you're investing in the intellectual property development, the research and development. For us that will be a priority. In fact, there will be many projects that will be brought forward as a consequence of that support for the program. They will be done on a very timely basis. In many cases, letting a contract is the quickest way to get to the answer.